As indicated in Table 1, two approaches have been taken to the development of antiviral chemotherapeutic agents. Both have met with some success although the availability of effective chemotherapeutic agents for the treatment of virus infections is very limited. This situation should change in the n
Immunogenetics of viral infections
โ Scribed by Maureen P Martin; Mary Carrington
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 307 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0952-7915
No coin nor oath required. For personal study only.
โฆ Synopsis
The HLA class I and II genes encode molecules that lie at the heart of the acquired immune response against infectious diseases. Associations between these polymorphic loci and genetically complex infectious diseases have been historically elusive, in contrast to the more obvious HLA associations with autoimmune diseases. High resolution molecular typing of large, clinically well-defined cohorts has begun to uncover evidence for the influence of HLA diversity on diseases of viral etiology, such as those caused by HIV-1, hepatitis B virus, hepatitis C virus and human papilloma virus. Combinations of HLA and KIR also appear to affect outcome to viral infection, supporting a role for HLA class I diversity in the innate immune response in addition to the acquired immune response.
๐ SIMILAR VOLUMES